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Abstract 
Objectives. Preterm birth (PTB) and low birth weight (LBW) are adverse birth outcomes 
of critical public health concern. This paper seeks to evaluate a Long Acting Reservable 
Contraception (LARC) intervention as part of Improving Community Outcomes for 
Maternal and Child Health (ICO4MCH). 
Methods. Aim one used birth certificate data to determine if the intervention contributed 
to decreased PTB and LBW. Aim two used county-level contraceptive data to determine 
if the intervention was associated with an increase in LARC methods. 
Results. Babies born in ICO4MCH counties had decreased odds of PTB but not LBW 
post implementation. Health departments in most but not all ICO4MCH counties had 
increased uptake of LARC methods post intervention. 
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Introduction 
Preterm and Low Birth Weight Birth 
Preterm birth (PTB) and low birth weight (LBW) are birth outcomes of critical 
public health concern and are leading causes of infant mortality in the United States 
(U.S.) (1,2). In 2017, about 17% of all infant deaths in the U.S. could be attributed to 
PTB, defined as the birth of an infant prior to 37 weeks gestation, and LBW, defined as 
the birth of an infant at a weight of less than 2500 grams (1,2). These adverse birth 
outcomes also impact surviving infants and families and can negatively impact a family’s 
long term financial and emotional wellbeing (3–5). Preterm and low birth weight infants 
can have problems with immaturity in their organs and higher incidence of intellectual 
disabilities, cerebral palsy, and impairments in hearing and vision throughout the life 
course (6–8). There is also evidence to suggest that infants born preterm or low birth 
weight are more likely to experience significant mental health problems and report lower 
overall functioning in adulthood when compared to infants born on time or at an adequate 
birth weight (9,10). 
In the U.S. in 2018, the average PTB rate was 9.8% and the average LBW rate 
was 8.2% (Table 1). Compared to other countries with similar economic profiles, the 
U.S. has considerably higher rates of  PTB and LBW (11–13). Moreover, there are 
significant disparities in the incidence of PTB and LBW by race and ethnicity in the U.S., 
with Black infants almost 1.5 - 2 times as likely to experience these adverse birth 
outcomes (14–16). In North Carolina, the average rate of PTB and LBW is slightly 
greater than in the national population, with 9.3% of infants being delivered at a low birth 
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weight and 10.4% being delivered preterm (16). Like the rest of the U.S., racial 
disparities in PTB and LBW births are stark in North Carolina. 
Table 1. LBW and PTB Rates per 1000 Live Births by Race-Ethnicity in the U.S. and 
North Carolina 
 U.S.  N.C.  
 
PTB* LBW** PTB* LBW** 
Overall 9.8 8.2 10.4 9.3 
White 9.0 7.0 9.3 7.6 
Black 13.6 13.7 13.8 14.2 
American Indian 11.3 8.1 11.9 11.8 
Asian 8.7 8.5 8.6 8.9 
Hispanic 9.4 7.4 8.9 7.5 
*PTB rates reflect data from 2016-2018 
**LBW rates reflect data from 2015-2017 
Note: data are from March of Dimes Peristats Database (16) 
 
Risk and protective factors for PTB and LBW occur both prior to and during 
pregnancy and include a broad range of interwoven factors. Haas et al. (21) found that 
demographic characteristics and pre-pregnancy risk factors together account for more 
than half of all risk for preterm delivery (13% and 39.8%, respectively). Risk factors of 
both PTB and LBW include: experiencing racism, high stress levels of the mother, 
low socioeconomic status (SES), and smoking during or before pregnancy (14,15,17–24). 
Important protective factors for PTB and LBW include: living in an area with access to 
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social support resources, access to regular medical care and medical insurance, access to 
high-quality prenatal care, and access to effective contraceptive methods (24–30). 
Long Acting Reversible Contraception  
Access to highly effective contraceptives for women who want them, such as 
long-acting reversible contraceptives (LARC), has been found to be an important 
protective factor against PTB and LBW (26,29,31,32). LARC contraceptive methods 
include intra-uterine devices (IUDs), such as Mirena or Paraguard, and implants 
(Nexplanon). Access to contraceptive methods may reduce PTB and LBW by providing 
women control of their reproductive life plan and allowing them to intentionally 
increase birth spacing and prevent unintended pregnancy (33–37). Access to highly 
effective contractive methods is particularly important for women who have recently 
experienced an adverse birth outcome like PTB, as they are at increased risk of having 
subsequent preterm births. However, increased birth spacing may reduce this risk in 
future births (35,37). LARC as a contraceptive method is particularly effective for 
increasing birth spacing and reducing unintended pregnancy; LARC methods are over 
99% effective, requires no daily or monthly maintenance, and can be removed when and 
if a woman desires to become pregnant (38,39). 
While short interpregnancy intervals (IPI) or birth spacing, especially spacing of 
less than six months, may be associated with increased odds of PTB and LBW, no clear 
mechanism has yet to be identified. Debate exists as to whether the apparent association 
between IPI and adverse birth outcomes is due to uncontrolled confounding 
characteristics (33,34). IPI may impact birth outcomes through folate depletion, 
incomplete uterine healing from a previous caesarean delivery, vertical transmission of 
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infections, or cervical insufficiency (34). Unintended pregnancy may increase PTB and 
LBW through increased stress, delayed initiation of prenatal care, or delayed cessation of 
higher risk behaviors that impact pregnancy outcomes (36,40–42) However, similar 
to IPI, few studies are able to control for the various confounding characteristics that may 
be associated with PTB and LBW and some question exists as to whether the association 
between adverse birth outcomes and unintended pregnancy may be due to confounders 
(36). 
IUDs and implants have been available in the U.S. for many decades, but the 
uptake of LARC as a method of contraception has increased rapidly among 
women in the last fifteen years (43–45). Despite increased utilization of, and desire for, 
LARC, several barriers exist at the clinic and provider level that can prolong or prevent 
women from accessing LARC as a contraceptive method. One such barrier is when clinic 
protocols or practices do not allow LARC insertion the same day the woman seeks it. 
When same day LARC insertion is not available for a woman, she must return for another 
visit to receive her LARC, which results in more time and potentially money as well as a 
risk for unintended pregnancy during the wait time (46–48). Several studies have found 
that women who have access to LARC insertion the same day they request it are more 
likely to receive their intended contraceptive method and that delaying insertion results in 
decreased utilization of these contraceptive methods (46,48). Other barriers to same day 
LARC insertion include clinician and patient misconceptions about LARC and lack of 
providers experienced in LARC insertion and removal (47,49–51). The utility of LARC 
as a safe and effective contraceptive method that can prevent unintended pregnancies and 
increase birth spacing and the general increase in prevalence and acceptance of LARC as 
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a contraceptive method over time has increased interest in same-day LARC insertion 
provisions as a potential public health prevention to reduce PTB and LBW. 
Improving Community Outcomes for Maternal and Child Health 
To address the high rates of PTB, LBW, and infant mortality in North Carolina, in 
2015 the North Carolina General Assembly allotted $2,500,000 (session law-241) in 
yearly funding to be distributed to local health departments (LHD) to implement 
Evidence-based strategies (EBS). The resulting program, Improving Outcomes for 
Maternal and Child Health (ICO4MCH), is an academic-practice partnership between the 
North Carolina Division of Public Health (DPH), the University of North Carolina at 
Chapel Hill Gillings School of Public Health, and LHDs receiving funding for 
ICO4MCH (52). The ICO4MCH program has three aims: 1) improving birth outcomes, 
2) reducing infant mortality, and 3) improving child health ages 0-5. 
ICO4MCH began in January of 2016 with a planning period lasting until June 
2016. From January - June 2016, planning funds were allocated to LHDs to develop 
community action teams, examine which EBSs were most appropriate for their specific 
context, and prepare applications for implementation funding to DPH (52). In total, 63 
LHDs received planning dollars, 56 were eligible for full ICO4MCH funding, and five 
grantees representing 13 counties as individual counties or as collaboratives received 
implementation funding for two years beginning in June 2016. Funding varied by grantee 
and ranged from $350,000-500,000 annually per grantee (52). 
Each funded county or collaborative selected at least one EBS to implement for 
each of the three aims: improve birth outcomes, reduce infant mortality, and improve 
child health for children aged 0-5. The two EBSs aimed at reducing infant mortality were 
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Tobacco Cessation and Prevention and Ten Steps for Successful Breastfeeding. The three 
EBSs focused on improving child health for children aged 0-5 were Positive Parenting 
Program (Triple P), Family Connects, and Clinical Efforts Against Secondhand Smoke 
Exposure (CEASE). All grantees implemented the same EBS aimed at improving birth 
outcomes, called Long-Acting Reversible Contraception (LARC). 
As part of the ICO4MCH LARC EBS, the LHD worked collaboratively with 
internal and external partners and with guidance from community action and 
implementation teams to implement the following: 1) Outreach and education to men and 
women of childbearing age about counselling and family planning methods, including 
LARC; 2) Outreach and training for public and private health care providers on LARC 
insertion and removal, and various other education topics (i.e. informed consent); 3) 
Improve access to same-day LARC insertion by increasing the number of 
clinics/providers that have a same-day insertion policy and practice and; 4) Identify and 
address barriers to same-day LARC insertion. 
As described above, one important area of focus during the first two years of 
program implementation was to increase access to LARC for women who wanted LARC. 
To do this, each collaborative worked with external clinic partners to improve access to 
same-day LARC insertion within the LHD by working towards developing same-day 
LARC insertion policies and practice. Same day LARC insertion policies indicate 
intentional incorporation of same day LARC insertion practice into a LHD and requires 
coordination with administration and providers. Same day LARC insertion practice was 
assessed to determine how often a woman requesting a LARC could receive LARC on 
the same day at any period of time throughout the quarter. Practice was measured as a 
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LHDs ability to “never”, “sometimes,” or “always” provide LARC insertion to clients on 
the same day it was requested. 
The overarching aim of this analysis is to: examine to what extent the LARC EBS 
implemented as part of the ICO4MCH program was associated with improved birth 
outcomes in 13 North Carolina counties receiving funding. Our analysis has two sub-
aims. Aim one was to determine if trends in birth outcomes, specifically PTB and LBW, 
improved after implementation of ICO4MCH in ICO4MCH counties compared to 
counties in NC where ICO4MCH was not implemented. In aim one we hypothesized the 
trend in the odds of babies born preterm or low birth weight in ICO4MCH counties 
would improve at a faster trajectory than trends in non-ICO4MCH counties. The second 
aim was to investigate whether trends in LARC utilization increased more rapidly after 
implementation of the ICO4MCH intervention in LHDs in ICO4MCH counties compared 
to LHDs in North Carolina counties without ICO4MCH. In aim two we hypothesized that 
the ICO4MCH LARC intervention would increase access to LARC and other family 
planning methods, thereby increasing the number of women adopting LARC compared to 
LHDs in NC without ICO4MCH. 
Methods 
Study Design and Setting  
We used a quasi-experimental design to evaluate the contribution of ICO4MCH on Aim 
1) PTB and LBW and Aim 2) LARC Utilization. Aim one was designed as a 
retrospective cohort analysis and aim two was designed as a retrospective cross-sectional 
analysis. 
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Selection of Treatment and Comparator Groups 
To test our two hypotheses, we sought to define a treatment and comparison group of 
North Carolina counties to use for analysis of both aims (figure 1). The treatment group 
for this evaluation included counties which ultimately received full ICO4MCH funding 
beginning in June 2016 (N=13 counties). Treatment counties consisted of two counties 
which received funding independently and 11 remaining counties that formed three 
collaboratives. In total, ICO4MCH funded five lead LHDs, called “grantees”, which 
consisted of 13 total counties and made up the treatment group for this analysis. 
In order to target the ICO4MCH program to areas in highest need with a substantial 
portion of births, the DPH set certain guidelines for county eligibility for ICO4MCH 
funding. A county or combination of counties was eligible for the funding if there were at 
least 1,000 births in 2014 and at least one of the following criteria were met: 
• Combined infant mortality rate of 10.8 or higher per 1,000 live births and 20 or 
more infant deaths in 2012-2014 
• An infant mortality disparity ratio (comparing Black non-Hispanic to White 
non-Hispanic) of 2.4 or higher in 2012-2014 
• Percent of children <18 years in poverty 37.7% or greater based on 2013 data 
• Percent of children <18 years of age is 11.1% of higher based on 2009-2013 
combined American Community Survey data.  
 
We aimed to establish a comparison group of North Carolina counties that would have a 
similar likelihood of receiving ICO4MCH funding as the ICO4MCH funded counties. 
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We therefore only included counties in the comparator group that would have been 
eligible for ICO4MCH but either did not apply or were not funded. Among the 100 North 
Carolina counties, only counties receiving planning money (n=63) and that met 
ICO4MCH eligibility criteria independently or as collaboratives (n=56) were selected as 
comparator counties. Among these 56 counties, six counties independently met eligibility 
criteria for the program and were included in the comparison group as independent 
counties. There was also one existing county health district, which included eight 
counties, that met criteria and was included in this analysis as a comparator group. 
Finally, eleven county aggregates were created where combinations of counties met 
eligibility criteria and were included as collaboratives in the comparison group. Overall, 
the comparator group thus included births from 18 groups or independent counties, which 
consisted of 56 total counties. In total, data from 69 of 100 North Carolina counties were 
included in either a treatment or comparison groups. These defined groups were used to 
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Figure 1. Treatment and Comparator Groups 
 
Aim One: Analysis of ICO4MCH Impact on Birth Outcomes  
Sample 
To investigate the first aim of this evaluation, all births from January 1, 2013 through 
December 31, 2018 (n=707,933) were from the North Carolina Consolidated Linked 
Birth File or Babylove file and were eligible for this analysis. The Babylove file 
integrates live birth certificate data with linked data from a variety of other public health 
data sources via a probabilistic linkage. The resulting file is comprised of eight sections: 
Birth file, Newborn Medicaid, Mother Medicaid, Newborn Medicaid Costs, Special 
Supplemental Nutrition Program for Women, Infants and Children (WIC), Infant Death, 
Hospital Discharge Newborn, and Hospital Discharge Maternal. 
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Multiple gestations (n=24,803) and births where plurality was unknown (n=2) were 
excluded from our analysis. Additionally, 398 births were excluded from the analysis 
because of implausible values of gestational age, birthweight, or maternal age (53). After 
these exclusions, 682,730 births from 100 NC counties were eligible for the analysis. The 
treatment group for the final analysis consisted of births that occurred in ICO4MCH 
counties (N=13 counties; N=181,350 births). The comparison group consisted of births 
that occurred in comparator counties (N=56 counties; N=300,619 births). In total, there 
were 481,969 births between 2013-2018 in the 69 North Carolina counties included in 
this analysis. 
Measures 
The primary outcomes in this analysis were PTB and LBW. PTB was defined using the 
obstetric estimate of gestation on the child’s birth certificate and LBW was defined using 
the birth weight variable from the child’s birth certificate. Both variables were then 
dichotomized into groups based on whether each outcome was present. Preterm birth was 
defined as a gestational age of <37 weeks and all eligible infants with a gestational age of 
<37 weeks were coded as a PTB. LBW was defined as a birth weight of <2500 grams and 
all eligible infants with a birth weight of <2500 were coded as LBW. 
The evaluation was designed as a retrospective cohort study with an ecological exposure, 
ICO4MCH funding for the LARC EBS. Thus, the main exposure was whether a mother 
resided in an ICO4MCH/treatment county versus a comparator county. County of 
residence of the mother was defined using the county of residence on the child’s birth 
certificate. The mother’s residence was then dichotomized into residence in a treatment 
or control county. 
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Confounders were selected for each outcome based on a literature review. Maternal age, 
smoking status, maternal education, Medicaid status, maternal race/ethnicity, pre-
pregnancy body mass index (BMI), child’s sex, previous preterm birth, parity, pregnancy 
weight gain, rurality, maternal diabetes, maternal hypertension, Women, Infants, and 
Children (WIC) enrollment, and concurrent programming were included as covariates for 
both outcomes (17,22,24,25,27,30,54–56). All adjusted models also included an 
adjustment for county aggregate (i.e. the groups outlined in the selection of treatment and 
comparator group section) to address the fact that observations are nested within county 
aggregates so we cannot assume that they are independent. A detailed description of all 
measures is included in the appendix (table 7). 
Analysis 
We began by tabulating pre-selected maternal and child characteristics by maternal 
residence in treatment or comparator counties (table 2). A Pearson chi-squared test was 
calculated to determine if treatment and comparator groups differed by these pre-selected 
characteristics. We then conducted a comparative interrupted time series difference in 
difference analysis for two outcomes PTB and LBW using logistic regression. In 
particular, we were interested in estimating the three-way interaction term for maternal 
residence in a treatment county, birth before or after the intervention, and continuous 
time in years in order to determine if there was a change in log odds of each outcome 
over time in the intervention group after the intervention (June 1, 2017) that was not seen 
over time in the comparator group after June 1, 2017. (57,58) (table 3). Unadjusted and 
adjusted models were conducted for each outcome separately. Analyses were stratified by 
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maternal race/ethnicity for both outcomes to examine whether the impact of ICO4MCH 
on birth outcomes differed by race/ethnicity. 
The logistic regression models were fit using generalized estimating equations (GEE) to 
account for correlation between siblings. Complete information on siblings was not 
available. Where possible, we matched siblings to each other via a fuzzy match approach, 
using maternal date of birth, maternal location of birth (state and county), maternal 
race/ethnicity, parity, and child’s month and year of birth. In some cases, we were unable 
to identify which children were siblings (i.e. there might be more than one mother/child 
pair with the same characteristics). In these cases, it was not possible to match siblings 
and these children were considered independent observations. 
While the ICO4MCH counties began to receive implementation funding in June of 2016, 
it was posited that it would take the counties a year to hire staff and fully implement the 
EBS according to the implementation science framework.  In addition, we also expected 
there to be a lag between outreach, education, family planning services and impact on 
birth outcomes. Therefore, the intervention date was set a priori to June 1, 2017 in our 
primary regression models anticipating that this is when we might start to see an impact 
on our outcomes. 
Because this difference in difference model assumes the time trends in the treatment and 
control groups are parallel prior to the start of the implementation of intervention (i.e. 
June 1, 2016), an analysis of trends prior to June 1, 2016 was also conducted. We 
calculated the log odds of the outcome during each month separately for the treatment 
and comparator groups. To assess the parallel trend assumption, we carried out a local 
weighted regression (lowess) of the log odds of the outcome on month-year of birth for 
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the treatment and comparator groups restricting to prior to June 1, 2016. We then 
generated and visually inspected graphs to look at trends over time in the treatment and 
comparator groups. The interaction between treatment and time prior to the intervention 
was also formally tested by running logistic regression models for each outcome for the 
time-period prior to the intervention period (January 1, 2013- June 1, 2016) using 
likelihood ratio tests. The parallel trends interaction test did not account for siblings using 
GEE (unlike the main model) as likelihood ratio tests cannot be conducted with a GEE 
model. 
Equation for the unadjusted difference in difference model 
𝑙𝑜𝑔𝑖𝑡(𝑃(𝑌 = 1)) = 
𝛽0 + 𝛽1𝑇𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 + 𝛽2𝑃𝑜𝑠𝑡 + 𝛽3𝑇𝑖𝑚𝑒 + 𝛽4𝑇𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 ∗ 𝑃𝑜𝑠𝑡 + 𝛽5𝑇𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡
∗  𝑇𝑖𝑚𝑒 
+𝛽6𝑃𝑜𝑠𝑡 ∗ 𝑇𝑖𝑚𝑒 + 𝛽7𝑇𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 ∗ 𝑃𝑜𝑠𝑡 ∗ 𝑇𝑖𝑚𝑒  
 
Aim Two: Analysis of ICO4MCH Impact on LARC Utilization 
Sample 
To investigate whether ICO4MCH funding increased utilization of LARC methods in 
LHDs, we obtained data on reported contraceptive methods from the Family Planning 
Branch of the North Carolina Division of Public Health. This dataset included county-
level data on contraceptive method choice for female-identifying clients who received 
services at each individual LHD or health system between 2013-2019 in all treatment and 
comparison counties (n=400,475). Data were collapsed into treatment (n=113,906) and 
comparison groups (n=286,569) using the same method outlined in the treatment and 
comparator group section. The data collection method for this data changed in 2018. This 
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change was to improve data quality. Between 2013-2017 data was obtained by the Family 
Planning Branch of the North Carolina Division of Public Health from the Health 
Information System Family Planning Annual Reports (HIS). Data from 2018 and 2019 
were obtained from the LHDs electronic medical records.  
Despite efforts to improve data quality, there were of female-identifying clients with 
“unknown” contraceptive method data (n=63,300). Data was unavailable for two years 
(2016-2017) for one comparator county included in this analysis. Data for these two years 
were coded as missing and this comparator county was included in the models. Data from 
2017 was reported possibly of poor quality as it was a transition year for LHDs to a new 
data collection system. For 2017, data for 6 individual counties was reported as missing 
‘one or more than one months’ worth of reporting data. Data for the other months were 
still provided and used in this analysis. For these groups, data was likely undercounted. 
The reported missing data was from both comparator (n=5) and treatment groups (n=2 
counties). 
If a county was part of a preexisting health system, contraceptive data were only 
available as an aggregate for the entire system between 2013-2017. Because counties 
were collapsed into existing or generated groups and these groups almost always 
overlapped with the existing health systems, data analysis was not meaningfully impacted 
by this change in data collection methods. 
All county groups were included in the analysis as outlined in the selection of treatment 
and comparator group section, with one exception. For one treatment group (which 
included five counties) we were unable to include one of these five counties. Because this 
county is part of an existing health system in which the other 2 counties in that health 
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system did not receive ICO4MCH funding, we had no way of extracting the individual 
county data from the health system to include the county’s data in the treatment group. 
We also could not exclude the county data from analysis as data was only available 
aggregated for the entire health system from 2013-2017. Instead, we included this one 
treatment county with its health system aggregate (in a comparator group) for all years 
(including 2017 and 2018). All other aggregate health system data between 2013-2017 
was coded with the correct exposure group for all years. 
Measure 
The primary outcome in this analysis was LARC utilization. LARC utilization was 
defined as the percentage of total female clients who chose a LARC for their 
contraceptive method each year. This outcome was defined using three variables: the 
number of clients who used an implant as a contraceptive method, the number of clients 
who used an IUD as a contraceptive method, and the total female-identifying clients. The 
total-female identifying clients included all clients, even if they were reported as having 
an “unknown” contraceptive method. For each year (2013-2019) total female clients who 
used IUDs and implants were summed and divided by the total number of female clients 
during that year. 
This study was designed as a retrospective cross-sectional analysis with an ecological 
exposure. Therefore, the main exposure was health department (in a particular county) in 
which a female client received health services. The county in which services were 
received was first grouped into treatment and comparison groups outlined in the 
treatment and comparison group section. They were then dichotomized between whether 
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a woman received services in an ICO4MCH/treatment county versus a comparator 
county. 
Analysis 
Because this difference in difference model assumes the time trends in the treatment and 
control groups are parallel prior to the start of the implementation of intervention (2017), 
an analysis of trends in LARC utilization between January 1, 2013 – January 1, 2016 was 
also conducted. We generated logistic regression models for the time-period prior to the 
intervention for treatment and comparator counties separately and ran a likelihood ratio 
test to compare trends. 
We first tabulated our outcome by exposure status and year (table 4). We then conducted 
a difference in difference time series analysis for our outcome, LARC utilization, using 
logistic regression. We ran one crude logistic regression model in which all five 
ICO4MCH treatment aggregates were included (model 1) and one crude logistic 
regression model in which we excluded one treatment group due to different trends in 
that group compared to others in the treatment group (model 2) (table 5). We were 
interested in estimating the interaction term for maternal residence in a treatment county 
and birth before or after the intervention to examine if there was a difference in the 
prevalence of LARC utilization in the treatment group after January 1, 2017 compared to 
the prevalence of LARC utilization in the comparator group after January 1, 2017. The 
intervention date was set a priori to January 2017 for two reasons. One, data were only 
available on a yearly basis and thus we could not set an intervention date at a mid-year 
point. Two, while the ICO4MCH counties began to receive implementation funding in 
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June of 2016, we posited that it would take the counties at least six months to a year to 
hire staff and fully implement the EBS. 
Finally, we generated predictive probabilities using the margins command in Stata for 
any model in which we saw a meaningful interaction to determine if the change seen 
among treatment counties was different than the change seen in comparator counties 
(table 6). 
Results 
Results of the ICO4MCH Program 
Grantees held trainings for LHD staff and partners external to the LHD on IUD and 
implant insertion and removal, tiered counselling, motivational interviewing, LARC 
reimbursement, and various other topics related to reproductive health. In year one, the 
collaboratives trained a total of 246 LHD staff and 87 staff external health department. In 
year two, the collaboratives trained 268 LHD staff and 98 staff external to the health 
department. Over the course of two years, grantees provided outreach and education to 
over 20,000 men and women of childbearing age. 
Grantees also worked to increase access to same day LARC insertion. A same day LARC 
insertion policy was defined as a written, documented policy of same-day LARC 
insertion practice in a LHD. Same day LARC insertion policies indicate intentional 
incorporation of same day LARC insertion practice into a LHD and requires coordination 
with administration and providers. In quarter one of implementation, one of the thirteen 
ICO4MCH counties had a same-day LARC insertion policy. By the end of year two, 
eight of the thirteen counties had a same day LARC insertion policy. The presence of a 
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policy, however, does not always mean that women always receive a LARC on the same 
day they requested it. Therefore, we also collected data on how often same day insertion 
was offered in practice on average. Data on same day LARC insertion practice was 
defined as a LHDs ability to “never”, “sometimes,” or “always” provide same-day LARC 
insertion to clients. In quarter one, four of the thirteen counties always offered same-day 
LARC insertion, six of the thirteen sometimes offered same-day LARC insertion, and 
three never offered same-day LARC insertion. By the end of year two, twelve of the 
thirteen counties always offered same-day LARC insertion and one county sometimes 
offered same-day IUD and implant insertion. Figure 2 displays ICO4MCH treatment 
counties’ progress in their same day LARC insertion practice and policy work from June 
2016-June 2018. 
Figure 2. Progress in Same-day LARC Insertion Policy and Practice 
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Results of Aim One: ICO4MCH Impact on Birth Outcomes 
After exclusions of births with multiple gestations, unknown plurality, or implausible 
values of gestational age, birthweight, or maternal age, there were 481,969 births between 
2013-2018 in the 69 North Carolina counties included in this analysis. The prevalence of 
PTB and LBW in our sample was 8.1% and 7.1% respectively. Most women were 
between the ages of 20-34 (78.4%), had obtained some college or graduated with a 
bachelors or an advanced degree (63.4%), and resided in an urban area (83.6%). More 
than half of women in the sample identified as White, 22.6% identified as Black, 15.1% 
identified as Hispanic, 4.3% identified as Asian, 3.3% identified as multiracial, and 1.5% 
identified as American Indian or Alaskan Native. Over half of the women were enrolled 
in Medicaid and 42.5% were enrolled in WIC. 
Mothers in ICO4MCH counties differed from mothers in control counties in several key 
risk and protective factors of PTB and LBW. Women in ICO4MCH counties were older 
and were more likely to be Black, American Indian, Asian, or Hispanic. Women in 
ICO4MCH were also less likely to have Medicaid and WIC, less likely to smoke and had 
higher education. 
Preterm Birth 
The parallel trends assumption was met for both adjusted models of PTB (LR ChiSq(1)= 
0.09, P= 0.77) and LBW (LR ChiSq(1)=0.09, P=.77). Prior to June 1, 2017, we observed 
no interaction between county of residence and continuous time (β= 0.00, [95% CI: -0.02, 
0.02]). However, the three-way interaction term, which tested the interaction between 
intervention, continuous time and county of residence, was statistically significant in the 
adjusted model of preterm birth (β= -0.13, [95% CI: -0.22, -0.03])  (Figure 3). Because 
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the interaction between treatment and continuous time is zero in this analysis, we can 
interpret the three-way interaction as the difference between the time slope in the 
treatment counties after the intervention compared to the time slope in the comparator 
counties after the intervention. Therefore, our findings indicate that there was a 
significant difference in the trends over time in preterm birth in treatment counties vs 
comparator counties after June 1, 2017. When the adjusted PTB model was stratified by 
race/ethnicity of the mother, the interaction between time, residence in a treatment county 
and birth before or after the intervention period were not statistically significant for Non-
Hispanic Black/African American (β= -0.09, [95% CI: -0.27, 0.08]) or Hispanic (β= -
0.11, [95% CI: -0.36, 0.14]) women. However, among Non-Hispanic White women, this 
interaction was statistically significant (β= -0.20, [95% CI: -0.35, -0.04]). Together, these 
findings indicate that the reduction seen in preterm birth over time post June 1, 2017 in 
ICO4MCH funded counties but not in comparator counties in the full model was largely 
driven by changes in the White population. (Figures 4-6). 
Low Birth Weight 
We did not see evidence of a three-way interaction between intervention, continuous time 
and county of residence in our adjusted LBW model (β= -0.02, [95% CI: -0.12, 0.08]) 
(figure 7). This indicates that there was not a significant difference in the trends over 
time in LBW in treatment counties vs comparator counties after June 1, 2017. No 
interaction in LBW by race/ethnicity was detected in stratified models. 
Results of Aim Two: ICO4MCH Impact on LARC Utilization 
In total, the contraceptive method choice of 400,475 female-identifying clients were 
included in this analysis. Among the entire sample, 11.3% of female-identifying clients 
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chose a LARC as their contraceptive method in 2013 whereas 20.0% chose a LARC as 
their contraceptive method in 2019. 
The parallel trends assumption was met for both model 1 (LR ChiSq(3)=1.61, P=0.66) 
and model 2 (LR ChiSq(3)= 2.30, P=.51). The interaction term for residence in a 
treatment county and contraceptive method choice before or after the intervention period 
(January 1, 2017) was not statistically significant in model 1 (β= 2.94, [95% CI: -0.53, 
6.41]). However, there was a significant change in prevalence of LARC utilization after 
January 1, 2017 in model 2 (β= 6.35, [95% CI: 2.77, 9.94]). These findings indicate that 
the change in the prevalence of LARC utilization in ICO4MCH counties after the 
intervention date (January 1, 2017) was significantly different than the change in percent 
of LARC utilization in comparator counties after the intervention date for four out of five 
ICO4MCH counties. The generated predictive probabilities calculated for model 2 (table 
6) indicate that, among treatment counties, the intervention period (2017-2019) and non-
intervention period (2013-2016) differed significantly in the prevalence of LARC 
utilization by 10.62%. The observed increase in LARC utilization among women 
between the two periods (2013-2016 and 2017-2019) was also seen in control counties 
and was also statistically significant at 4.27%. However, the increase of LARC utilization 
in treatment counties was significantly larger than the increase in control counties by 
6.35%. Therefore, we observed an increase in the intervention period among treatment 
counties that was significantly greater than the observed increase in the intervention 
period among the control counties. 
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Discussion 
As hypothesized, we saw a statistically significant decrease in preterm birth in treatment 
counties over time after June 1, 2017 but did not see a similar decrease in preterm birth in 
comparator counties after June 1, 2017. We conclude that the ICO4MCH intervention 
was associated with a decrease in preterm birth in ICO4MCH counties. Additional 
models stratified by race-ethnicity for the PTB model (Non-Hispanic-White, Non-
Hispanic Black, and Hispanic) indicated that the intervention was associated with a 
significant decrease in preterm birth among Non-Hispanic White mothers, but not among 
Non-Hispanic Black or Hispanic mothers. However, counter to our hypothesis, we did 
not observe a statistically significant decrease in LBW in treatment counties over time 
after June 1, 2017 compared to LBW in control counties over time after June 1, 2017. 
Finally, we also found that the LARC EBS led to an increase in LARC utilization in all 
but one ICO4MCH counties compared to comparators after the implementation of the 
ICO4MCH intervention. This observation was counter to our hypothesis, as we expected 
LARC utilization to increase in all ICO4MCH counties after implementation of the EBS. 
The lack of increased LARC utilization in this one county was likely due to repeated 
natural disaster events that disproportionately impacted this county compared to others in 
ICO4MCH, as discussed below. The increase in the prevalence of LARC was observed in 
both treatment and comparator counties but the increase was significantly greater among 
ICO4MCH counties in our second model, which excluded the county with hypothesized 
decreased implementation success of the EBS. 
It is unclear why we observed a decrease in PTB only among non-Hispanic White 
women. It is possible that uptake of LARC differed by race-ethnicity. Unfortunately, 
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program-level data and the secondary family planning utilization data were not 
disaggregated by race-ethnicity. We were therefore unable to determine if program reach 
or contraceptive method selection differed by race/ethnicity or any other demographic 
characteristics. In the future, program-level data will be collected in a way that allows for 
data to be disaggregated by race-ethnicity and age to help determine if the receipt of the 
LARC intervention may vary by demographic characteristics. 
Trends in LARC utilization nationwide indicate that LARC receipt may differ by race-
ethnicity of the woman seeking contraception, with Black and Hispanic mothers possibly 
more likely to select a LARC contraceptive method (45,59,60). Kavanaugh and Jerman 
(45) reported the prevalence of LARC usage by race/ethnicity for women 15-44 in 2014 
as 13% among Non-Hispanic White women, 15% among Non-Hispanic Black women, 
14% among women of multiple of other race, and 18% among Hispanic White women. 
Another study on postpartum LARC insertion in North Carolina by Goulding, et al. (59) 
observed increased odds of postpartum LARC insertion among Hispanic White women 
and Non-Hispanic Black women when compared to Non-Hispanic White women. It is 
unknown if Black and Hispanic women who received family planning services at a LHD 
with ICO4MCH funding were already more likely to have a LARC (and therefore not 
receive one as a result of the program). However, it is possible that an initial lower 
prevalence of LARC among White women could in part explain why we only observed a 
reduction in PTB among this population. 
Despite possible increased selection of LARC contraceptive methods among Black and 
Hispanic women, the coercive history of contraception and sterilization practices in the 
U.S. cannot be overlooked when discussing the potential differential impact of this EBS 
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and on the utilization of LARC methods by Women of Color. A qualitative research 
study of 50 women by Higgins, Kramer, & Ryder (61) found that Women of Color were 
more likely than Non-Hispanic White women to expect providers to recommend LARC 
and were also more likely to perceive the recommendation as motivated by their race or 
income. Future data collection for the ICO4MCH program should seek to collect patient-
level perceptions of the LARC intervention and patient-level satisfaction with their 
contraceptive method of choice. The collection of this information would help program 
staff disentangle the complex factors that may be driving the observed differences in 
PTB. 
Another possible explanation for these findings could be that the mechanisms driving 
PTB differed by race-ethnicity of the mother. It is possible that the nearly two-fold 
increased likelihood of preterm birth among Non-Hispanic Black women is driven by a 
mechanism not targeted through increased access to LARC and other family planning 
services. We hypothesized that the intervention would impact PTB through the reduction 
of unintended pregnancy and through increased birth spacing. It is possible that the 
selection of this EBS to reduce PTB may not have targeted the more systemic/structural 
mechanisms (i.e. Racism) that drive the disparities seen in PTB for Non-Hispanic Black 
and Hispanic women. Finally, the theory of racism as a fundamental cause of health 
inequities may in part explain why ICO4MCH only contributed to reductions in preterm 
birth among Non-Hispanic White women (62). Phelan and Link (62) explain that health 
promotion interventions tend to first impact those with more privilege and more access to 
resources because they are the first to use the information to advantage their own health. 
It is possible continued implementation of this EBS would lead to improved outcomes for 
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all women if implemented for a longer period of time. Future interventions to reduce 
adverse birth outcomes should consider a specific focus on equity in birth outcomes as 
opposed to birth outcomes in general. 
We expected ICO4MCH would have a similar impact on both PTB and LBW as we 
hypothesized a similar mechanism of action between the intervention and both birth 
outcomes (i.e. an increase access to contraception including LARC would lead to 
increased birth interval and reduced unintended pregnancy). Similarly, PTB is one of the 
leading causes of LBW, so we hypothesized the two outcomes would respond similarly to 
the EBS. In contrast, we only observed an impact on PTB. Our evaluation is not the first 
to find a significant impact of a LARC intervention for PTB but not for LBW. An 
evaluation of the Colorado Initiative, which sought to increase family planning services 
and LARC utilization for birthing people in Colorado through funding at the clinic level, 
also found a significant reduction in PTB but not LBW trends following implementation 
of the program (26). Evaluation of the Colorado Family Planning Initiative also 
documented a significant inverse relationship between higher county-level proportion of 
LARC utilization and county-level PTB but not LBW (26). Therefore, it is possible that 
interventions seeking to increase access to LARC may more effectively impact drivers of 
PTB and not LBW. However, future research is needed to disentangle mechanisms that 
impact the relationship between LARC utilization and adverse birth outcomes. 
It is unclear why we observed an increase in LARC utilization from 2017-2019 among 
only 4 of 5 treatment groups. The one treatment county excluded in model 2 of the LARC 
utilization analysis was the only group among both treatment and comparator groups in 
which we observed a decline in LARC utilization among female-identifying clients 
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between 2017-2019 (n=23). From 2013-2017, trends in LARC utilization in this 
treatment county were similar to trends in other treatment and control groups (i.e. a 
steadily increase over time from 2013-2017). The general increase in prevalence of 
LARC as a contraceptive method observed among the entire sample has also been 
documented in several other nationwide studies (43–45). The observed decrease in LARC 
utilization for this one county began in 2017. 
Discussions with stakeholders revealed that these trends could be a result of several 
county-specific events. This treatment county experienced three hurricanes throughout 
the treatment period, one of which had a devastating impact on the LHD and surrounding 
area and occurred at the beginning of the intervention period. The hurricanes caused 
significant damages and clinic closures in the LHD. Stakeholders also revealed that the 
county had high turnover among their LARC providers and that there were times 
throughout the treatment period in which there was not a provider available to perform 
LARC insertion. 
This treatment county is also demographically different than most other counties included 
in the analysis of LARC utilization and we were unable to control for potential 
confounders in the LARC models. This county is rural with over 40% of the population 
identifying as American Indian or Indigenous. Studies that determine prevalence of 
contraceptive use by race-ethnicity often group American Indian women as “other or 
more than one race”, so it is unclear whether LARC utilization is less common among 
this population (44,45). An analysis of reproductive health among American Indian 
women using the 2002 National Survey of Family Growth found that about 61% of urban 
American Indian women ages 15-24 did not use any form of contraception (63). 
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However, these data were from 2002 and included only American Indian women who 
resided in an urban area. Because the population of this one county is rural and because 
LARC utilization has increased nationwide substantially since 2002, these findings may 
not be representative of contraceptive practices among American Indian women in this 
county. Future studies on reproductive life planning practices and contraceptive methods 
of choice among rural American Indian women are needed to make better inferences 
about why we may have seen a decline in LARC utilization in this county despite having 
the LARC intervention. 
Finally, this grantee consisted of one rural county. Therefore, any problems with data 
quality could have been more impactful than data quality issues in a more densely 
populated county or among a collaborative with multiple counties. This sparsely 
populated rural county could have also been impacted by saturation such that the number 
of women who wanted a LARC within this county who attend the LHD received it and 
therefore the trends in women using LARC was impacted. 
Limitations 
There were several limitations to this evaluation. First, only 1.5 years of birth certificate 
data was available post intervention period (June 1, 2017) at the time of this analysis 
whereas change in the long-term goals were expected about 3-5 years following 
intervention. We plan to examine whether our findings hold once 2019 data become 
available. As mentioned above, program-level data were not available disaggregated by 
race and ethnicity, and therefore we were not able to discern whether utilization of family 
planning services varied by the race or ethnicity of the women. We were unable to 
comprehensively account for siblings in the birth outcomes models. When possible, 
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siblings were matched to each other via a fuzzy merge approach, using maternal date of 
birth, maternal location of birth (state and country), maternal race/ethnicity, parity, and 
child’s month and year of birth. There were likely cases where sibling pairs were counted 
as individual observations, for example when more than one mother and child pairs had 
similar characteristics. 
In the LARC utilization models, we were unable to adjust for any cofounders. The data 
source for contraceptive data also changed in 2017, which was the start of the 
intervention period. We were cautioned that data for 2017 may be of poor quality as the 
LHDs were preparing for the new data system. Finally, data reported for years 2013 and 
2014 had high incidence of female clients with “unknown” contraceptive methods. 
Therefore, data from years 2013, 2014 and 2017 should be interpreted with caution. 
This evaluation provides support that the ICO4MCH LARC EBS contributed to a 
reduction in PTB among treatment counties. However, another limitation to this 
evaluation is that, while birth outcomes models controlled for various confounding 
variables and other funded programs, grantees implement three EBSs as part of the 
ICO4MCH program. As a result, it is hard to discern which EBS resulted in change seen 
in preterm births in treatment counties as funding for and implementation of the EBSs all 
began June 1, 2016. 
Four of five of the grantees also implemented another EBS aimed at smoking cessation 
that could have impacted PTB in treatment counties. Smoking is another risk factor for 
PTB and LBW, irrespective of other risk factors (20). Smoking has been shown to cause 
fetal growth restriction and placental complications (20) In a recent study of 1,390,742 
births, smoking explained nearly 33% of the variation in preterm birth among extremely, 
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very, and moderately preterm infants (22). Two of the five grantees implemented the 
Tobacco Cessation and Prevention aimed at decreasing primary, secondary and tertiary 
tobacco exposure. As part of the intervention, LHDs increased access to direct clinical 
support around tobacco use, screening and counselling using the 5As (Ask, Advice, 
Assess, Assist, Arrange) and Certified Tobacco Treatment Specialists (CTTSs). Two of 
the five grantees implemented Clinical Efforts Against Secondhand Smoke Exposure 
(CEASE). This intervention is also a tobacco cessation program which provides cessation 
resources to parents during a child’s health care visit. Both grantees implementing these 
interventions also worked to increase access to the QuitlineNC, a statewide free tobacco 
cessation program. Any of these smoking cessation programs may have impacted preterm 
birth. We adjusted for other Reproductive Life Planning and Infant Mortality Reduction 
funding across the state, but we were unable to control for tobacco prevention and control 
funding, programs and policy external to ICO4MCH which may have an impact on PTB 
and LBW that was not accounted for. However, our birth outcomes models did control by 
for individual level smoking status. 
Implications 
Despite evidence that LARC can reduce unintended pregnancy and increase birth 
spacing, there are few studies which evaluate increasing access to LARC as an 
intervention for preventing adverse birth outcomes, like PTB and LBW. This evaluation 
was structured as a quasi-experimental difference in difference time series analysis with 
two primary aims: 1) to determine if trends in birth outcomes, specifically preterm and 
low birth weight births, improved after implementation of ICO4MCH in ICO4MCH 
counties compared to other counties in NC and 2) to determine if LARC utilization 
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increased after implementation of the ICO4MCH intervention in local health departments 
in ICO4MCH counties compared to LHDs in North Carolina. 
To our knowledge, this is the second study to find that funding to increase access to 
LARC methods may be effective at decreasing PTB but not LBW (26). While the PTB 
model was statistically significant overall, stratified models revealed a more nuanced 
story. While the ICO4MCH LARC intervention did not specifically seek to reduce racial 
disparities in PTB and LBW, it is noteworthy and concerning that findings suggest PTB 
was reduced mostly among those with the lowest overall incidence of PTB. Future 
reproductive life planning and LARC interventions should seek to intentionally evaluate 
the effectiveness of these interventions on both PTB and LBW, and should also seek to 
set up interventions so that program-level data can be disaggregated by race and ethnicity 
to better understand program impact. Future RLP/LARC interventions should also 
consider monitoring program uptake and/or conducting process evaluations to see who is 
benefitting from RLP/LARC programs prior to conducting evaluations on program 
impact. Future RLP/LARC programs should also seek to capture patient voice 
and satisfaction with the clinical encounter to ensure equal access and equity in 
outcomes. Finally, this evaluation lends support to LARC interventions as an effective 
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Table 2. Characteristics of women (n=481,969) in 69 North Carolina Counties who Gave Birth Between 
January 1, 2013 and December 31, 2018 










  N (%) N (%) N (%) <.001 
PTB (<37 weeks) 
       
     No 442,715 91.90 276,427 91.99 166,288 91.73 
 
     Yes 39,044 8.10 24,055 8.01 14,989 8.27 
 






LBW (<2500 grams)        
     No 447,630 92.90 279,873 93.10 167,757 92.50 <.001 
     Yes 34,251 7.10 20,697 6.90 13,554 7.50  
     Missing 88  49  39   
Maternal Age 
      
<.001 
     Under 20 years 29,734 6.17 19,074 6.34 10,660 5.88 
 
     20-24 years 109,838 22.79 71,037 23.63 38,801 21.40 
 
     25-29 years 139,464 28.94 87,846 29.22 51,618 28.46 
 
     30-34 years 128,362 26.63 77,864 25.90 50,498 27.85 
 
     35-39 years 61,435 12.75 36,895 12.27 24,540 13.53 
 
     40 or more years 13,129 2.72 7,899 2.63 5,230 2.88 
 






Maternal Smoking Status 
   
<.001 
     Non-smoker 422,581 87.70 259,249 86.25 163,332 90.09 
 
     Stopped Before Pregnancy 17,553 3.64 11,478 3.82 6,075 3.35 
 
     Stopped After Pregnancy 10,163 2.11 6,864 2.28 3,299 1.82 
 
     Continued Smoking 31,575 6.55 22,978 7.64 8,597 4.74 
 






Maternal Education Level 
      
<.001 
     Less than High School 69,628 14.49 41,343 13.79 28,285 15.63 
 
     High School Grad or GED 106,474 22.15 69,575 23.21 36,899 20.40 
 
     Some College 148,807 30.96 96,527 32.20 52,280 28.90 
 
     Bachelor's Degree or More 155,756 32.40 92,301 30.79 63,455 35.07 
 






Maternal Medicaid Status 
      
<.001 
     No 226,989 47.10 137,370 45.70 89,619 49.40 
 
     Yes 254,980 52.90 163,249 54.30 91,731 50.60 
 
Maternal Race/ Ethnicity 
     
<.001 
     Non-Hispanic White 256,342 53.23 180,822 60.20 75,520 41.69 
 
     Non-Hispanic Black or    
     African American 
108,675 22.57 58,405 19.44 50,270 27.75 
 
     Non-Hispanic American     
     Indian or Alaskan Native 
7,102 1.47 1,716 0.57 5,386 2.97 
 
     Non-Hispanic Asian or      
     Pacific Islander 
20,811 4.32 10,704 3.56 10,107 5.58 
 
     Multiracial or Other 15,732 3.27 8,934 2.97 6,798 3.75 
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     Hispanic 72,892 15.14 39,809 13.25 33,083 18.26 
 






Maternal Pre-pregnancy BMI 
     
<.001 
     Underweight 17,772 3.77 11,334 3.85 6,438 3.62 
 
     Normal 212,025 44.94 130,221 44.28 81,804 46.02 
 
     Overweight 118,310 25.08 72,997 24.82 45,313 25.49 
 
     Obese 123,710 26.22 79,509 27.04 44,201 24.87 
 







      
0.44 
     Male 246,307 51.10 153,500 51.10 92,807 51.20 
 
     Female 235,658 48.90 147,116 48.90 88,542 48.80 
 







     
<.001 
     No 465,855 96.66 291,298 96.91 174,557 96.26 
 
     Yes 16,077 3.34 9,295 3.09 6,782 3.74 
 







      
<.001 
     Nulliparous 198,385 41.17 122,466 40.74 75,919 41.87 
 
     1 prior birth 154,114 31.98 97,766 32.52 56,348 31.08 
 
     2-3 prior births 108,725 22.56 67,894 22.59 40,831 22.52 
 
     4 or more prior births 20,687 4.29 12,463 4.15 8,224 4.54 
 






Pregnancy Weight Gain 
     
<.001 
     Less than adequate 98,534 21.12 60,716 20.86 37,818 21.55 
 
     Adequate 139,665 29.93 86,621 29.76 53,044 30.23 
 
     Excessive 228,373 48.95 143,771 49.39 84,602 48.22 
 







   
0.00 <.001 
     Urban 402,865 83.59 244,978 81.50 157,887 87.10 
 
     Non-Metro, Urban 71,872 14.91 49,676 16.50 22,196 12.20 
 
     Rural 7,232 1.50 5,965 2.00 1,267 0.70 
 
Concurrent RLP or IMR Funding 
     
<.001 
     No 408,937 84.85 246,477 81.99 162,460 89.60 
 
     Yes 73,032 15.15 54,142 18.00 18,890 10.40 
 
Diabetes (prior to or during pregnancy) 
    
0.38 
     No 448,947 93.16 280,093 93.18 168,854 93.12 
 
     Yes 32,973 6.84 20,491 6.82 12,482 6.88 
 






Hypertension (prior to or during pregnancy) 
    
0.40 
     No 440,875 91.48 274,904 91.46 165,971 91.50 
 
     Yes 41,045 8.52 25,680 8.54 15,365 8.50 
 






Enrolled in WIC 
      
<.001 
     No 277,171 57.51 166,280 55.30 110,891 61.10 
 
     Yes 204,798 42.49 134,339 44.70 70,459 38.90 
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Table 3. Adjusted Difference in Difference Models for Preterm Birth (n=464,983) and 
Low Birth Weight (465,057) 
Model PTB Model LBW Model 
  Beta (95% CI) Beta (95% CI) 
Treatment County 0.33 
(0.21 - 0.45) 
0.33 
(0.20 - 0.45) 
Birth after May 31, 2017 -0.07 
(-0.13 - -0.01) 
-0.04 
(-0.11 - 0.02) 
Interaction between Treatment County 
and birth after May 31st, 2017 
0.09 
(-0.01 - 0.19) 
0.00 
(-0.11 -0.11) 
Time in years (Centered at June 1, 
2017) 
0.00 
(-0.01 - -0.1) 
0.02 
(0.01 - 0.03) 
Interaction between Treatment County 
and time in years 
0.00 
(-0.02 - 0.02) 
-0.01 
(-0.03 - 0.01) 
Birth after May 31st, 2017 and time in 
years 
0.02 
(-0.03 - 0.08) 
-0.01 
(-0.08- 0.05) 
Interaction between Treatment County, 
a birth after May 31st, 2017, time in 
years 
-0.12 
(-0.22 - -0.03) 
-0.02 
(0.12 - 0.08) 
Note: Confounders included in models are: Maternal age (Categories: Under 20 years, 
20-24 years, 25-29 years, 30-34 years, 35-39 years, 40 years); Maternal smoking status 
(Categories: Non-smoker, Stopped before pregnancy, Stopped after pregnancy, 
Continued smoking); Maternal Education (Categories: Less than high school, High 
School or GED, Some college, Bachelor's degree or more); Maternal Medicaid Status 
(Categories: Enrolled in Medicaid, not enrolled in Medicaid); Maternal race/ethnicity 
(Categories: Non-Hispanic White, Non-Hispanic Black or African American, Non-
Hispanic American Indian or Alaskan Native, Non-Hispanic Asian or Pacific Islander, 
Multiracial or Other, Hispanic); Maternal Pre-Pregnancy BMI (Categories: 
Underweight, Normal, Overweight, Obese); Child’s Sex (Categories: Male, Female); 
Previous PTB (Categories: Previous preterm birth, No prior preterm birth); Parity 
(Categories: Nulliparous, 1 prior birth, 2-3 prior years, 4 or more prior births); 
Pregnancy weight gain (Categories: Adequate, Excessive, Less than Adequate); 
Diabetes (Categories: No diabetes, Pre-pregnancy or gestational diabetes); 
Hypertension (Categories: No hypertension, Pre-pregnancy or gestational 
hypertension); WIC Enrollment (Categories: Enrolled in WIC, Not enrolled in WIC); 
Rural-Urban Continuum (Categories: Urban, Non-metro urban, Rural); Concurrent 
reproductive life planning or infant mortality reduction funding (Categories: 
Concurrent funding, No concurrent funding); County Aggregate (Categories: Outlined 
in the Selection of Treatment and Comparator Groups section of the methods). 
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Table 4. Trends in Percentage of LARC Utilization by Year Between 2013-2019 
All Counties (N = 400,475) 














8569 7310 7597 8394 8806 8780 10019 
         
Total Female 
Clients 
76012 61472 56054 54365 52863 49676 50033 




11.27% 11.89% 13.55% 15.44% 16.66% 17.68% 20.03% 
Treatment Counties and Collaboratives (N = 113,906) 














1761 1344 1756 2283 2119 2725 2611 
  
       
Total Female 
Clients 
23079 16699 18221 15833 13796 13722 12556 
  




7.63 8.05 9.64 14.42 15.36 19.86 20.8 











Control Counties and Collaboratives (N = 286,569) 














6808 5966 5841 6111 6687 6055 7408 
  
       
Total Female 
Clients 




12.86 13.32 15.44 15.86 17.12 16.84 19.77 












Table 5. Multilevel Regression Models for Percentage of LARC utilization in treatment county 
and intervention period (N = 400,475) 
  Model 1A: Model 1B: Model 2A: Model 2B: 
 All Treatment Counties 4 of 5 Treatment Counties 
   Beta (95% CI) Beta (95% CI)  Beta (95% CI)  Beta (95% CI) 
Treatment county -1.08 
(-6.21 – 4.05) 
-2.34 
(-7.68 - 2.10) 
-0.18 
(-5.83 – 5.48) 
-2.9 




(3.47 – 6.37) 
4.27 
(2.64 - 5.90) 
5.44 





and treatment county 
- 2.94 
(-.53 - 6.41) 
- 6.35 
(2.77 - 9.94) 
Intercept 11.96 
(9.49 – 14.43) 
12.24 




(9.74 - 14.74) 




























Treatment county 19.96  9.34  10.62* 
Control county 16.51  12.24  4.27* 
 Difference -  -  6.35* 
Note: * p<.05 
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Figure 3. Preterm Birth Model 
 
Figure 4. Preterm Birth Model – Only Non-Hispanic Black/African American Mothers 
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Figure 5. Preterm Birth Model – Only Non-Hispanic White Mothers 
 
Figure 6. Preterm Birth Model – Only Hispanic Mothers 
 
 
ICO4MCH LARC INTERVENTION EVALUATION  45 












ICO4MCH LARC INTERVENTION EVALUATION  46 
References 
1.  Ely DM, Driscoll AK. Infant mortality in the United States, 2017 : data from the 
period linked birth/infant death file. Natl Vital Stat Rep. 2019;68(10):1–19.  
2.  Kochanek K, Murphy S, Xu J, Arias E. Deaths: Final Data for 2017. Natl Vital Stat 
Rep. 2019;68(9):1–76.  
3.  Henderson J, Carson C, Redshaw M. Impact of preterm birth on maternal well-
being and women’s perceptions of their baby: a population-based survey. BMJ 
Open. 2016;6(10):e012676.  
4.  Lakshmanan A, Agni M, Lieu T, Fleegler E, Kipke M, Friedlich PS, et al. The 
impact of preterm birth <37 weeks on parents and families: a cross-sectional study 
in the 2 years after discharge from the neonatal intensive care unit. Health Qual Life 
Outcomes. 2017;15(1):38.  
5.  Roque ATF, Lasiuk GC, Radünz V, Hegadoren K. Scoping Review of the Mental 
Health of Parents of Infants in the NICU. J Obstet Gynecol Neonatal Nurs JOGNN. 
2017;46(4):576–87.  
6.  Aarnoudse-Moens CSH, Weisglas-Kuperus N, van Goudoever JB, Oosterlaan J. 
Meta-analysis of neurobehavioral outcomes in very preterm and/or very low birth 
weight children. Pediatrics. 2009;124(2):717–28.  
7.  Aylward GP. Update on neurodevelopmental outcomes of infants born prematurely. 
J Dev Behav Pediatr JDBP. 2014;35(6):392–3.  
8.  Blencowe H, Cousens S, Chou D, Oestergaard M, Say L, Moller A-B, et al. Born 
Too Soon: The global epidemiology of 15 million preterm births. Reprod Health. 
2013 Nov 15;10(1):S2.  
9.  Lærum AMW, Reitan SK, Evensen KAI, Lydersen S, Brubakk A-M, Skranes J, et 
al. Psychiatric Disorders and General Functioning in Low Birth Weight Adults: A 
Longitudinal Study. Pediatrics [Internet]. 2017 Feb 1 [cited 2020 Nov 13];139(2). 
Available from: http://pediatrics.aappublications.org/content/139/2/e20162135 
10.  Nosarti C, Reichenberg A, Murray RM, Cnattingius S, Lambe MP, Yin L, et al. 
Preterm Birth and Psychiatric Disorders in Young Adult Life. Arch Gen Psychiatry 
[Internet]. 2012 Jun 1 [cited 2020 Nov 17];69(6). Available from: 
http://archpsyc.jamanetwork.com/article.aspx?doi=10.1001/archgenpsychiatry.2011.
1374 
11.  Blencowe H, Krasevec J, Onis M de, Black RE, An X, Stevens GA, et al. National, 
regional, and worldwide estimates of low birthweight in 2015, with trends from 
2000: a systematic analysis. Lancet Glob Health. 2019 Jul 1;7(7):e849–60.  
ICO4MCH LARC INTERVENTION EVALUATION  47 
12.  MacDorman MF, Matthews TJ, Mohangoo AD, Zeitlin J. International comparisons 
of infant mortality and related factors: United States and Europe, 2010. Natl Vital 
Stat Rep Cent Dis Control Prev Natl Cent Health Stat Natl Vital Stat Syst. 2014 Sep 
24;63(5):1–6.  
13.  OECD Family Database. OECD Family Database: Low Birth Weight (Child 
Outcomes) [Internet]. OECD Health Statistics; 2019 [cited 2020 Oct 10]. (Health at 
a Glance). Available from: 
https://www.oecd.org/els/family/CO_1_3_Low_birth_weight.pdf 
14.  Lu MC, Kotelchuck M, Hogan V, Jones L, Wright K, Halfon N. Closing the Black-
White Gap in Birth Outcomes: A Life-course Approach. Ethn Dis. 2010;20(1 0 
2):S2-62–76.  
15.  MacDorman MF. Race and Ethnic Disparities in Fetal Mortality, Preterm Birth, and 
Infant Mortality in the United States: An Overview. Semin Perinatol. 
2011;35(4):200–8.  
16.  National Center for Health Statistics. Peristats [Internet]. March of Dimes; 2019. 
Available from: www.marchofdimes.org/peristats 
17.  Blumenshine P, Egerter S, Barclay CJ, Cubbin C, Braveman PA. Socioeconomic 
Disparities in Adverse Birth Outcomes: A Systematic Review. Am J Prev Med. 
2010 Sep 1;39(3):263–72.  
18.  Braveman PA, Heck K, Egerter S, Marchi KS, Dominguez TP, Cubbin C, et al. The 
Role of Socioeconomic Factors in Black–White Disparities in Preterm Birth. Am J 
Public Health. 2015 Apr;105(4):694–702.  
19.  Dominguez TP, Dunkel-Schetter C, Glynn LM, Hobel C, Sandman CA. Racial 
Differences in Birth Outcomes: The Role of General, Pregnancy, and Racism Stress. 
Health Psychol Off J Div Health Psychol Am Psychol Assoc. 2008 Mar;27(2):194–
203.  
20.  Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of 
preterm birth. The Lancet. 2008;371(9606):75–84.  
21.  Haas JS, Fuentes-Afflick E, Stewart AL, Jackson RA, Dean ML, Brawarsky P, et al. 
Prepregnancy Health Status and the Risk of Preterm Delivery. Arch Pediatr Adolesc 
Med. 2005;159(1):58–63.  
22.  Räisänen S, Gissler M, Saari J, Kramer M, Heinonen S. Contribution of Risk 
Factors to Extremely, Very and Moderately Preterm Births – Register-Based 
Analysis of 1,390,742 Singleton Births. PLoS One San Franc. 2013 
Apr;8(4):e60660.  
23.  Romero R, Dey SK, Fisher SJ. Preterm labor: One syndrome, many causes. Science. 
2014 Aug 15;345(6198):760–5.  
ICO4MCH LARC INTERVENTION EVALUATION  48 
24.  Tucker CM, Berrien K, Menard MK, Herring AH, Daniels J, Rowley DL, et al. 
Predicting preterm birth among participants of North Carolina’s Pregnancy Medical 
Home Program. Matern Child Health J. 2015 Nov;19(11):2438–52.  
25.  Debiec KE, Paul KJ, Mitchell CM, Hitti JE. Inadequate prenatal care and risk of 
preterm delivery among adolescents: a retrospective study over 10 years. Am J 
Obstet Gynecol. 2010 Aug;203(2):122.e1-122.e6.  
26.  Goldthwaite LM, Duca L, Johnson RK, Ostendorf D, Sheeder J. Adverse Birth 
Outcomes in Colorado: Assessing the Impact of a Statewide Initiative to Prevent 
Unintended Pregnancy. Am J Public Health. 2015 Jul 16;105(9):e60–6.  
27.  Kent ST, McClure LA, Zaitchik BF, Gohlke JM. Area-level risk factors for adverse 
birth outcomes: trends in urban and rural settings. BMC Pregnancy Childbirth. 2013 
Jun 10;13(1):129.  
28.  Riley C, Roy B, Herrin J, Spatz E, Silvestri MT, Arora A, et al. Do pregnant women 
living in higher well-being populations in the USA experience lower risk of preterm 
delivery? A cross-sectional study. BMJ Open. 2019 Apr 1;9(4):e024143.  
29.  Rodriguez MI, Chang R, Thiel de Bocanegra H. The impact of postpartum 
contraception on reducing preterm birth: findings from California. Am J Obstet 
Gynecol. 2015;213(5):703.  
30.  Rosenberg D, Handler A, Rankin KM, Zimbeck M, Adams EK. Prenatal care 
initiation among very low-income women in the aftermath of welfare reform: does 
pre-pregnancy Medicaid coverage make a difference? Matern Child Health J. 2007 
Jan 1;11(1):11–7.  
31.  Sackeim MG, Sammel M, Gurney EP, Schreiber CA. 946: Rapid repeat pregnancy: 
prevalence and risk factors in an urban population. Am J Obstet Gynecol. 2018 Jan 
1;218(1):S560–1.  
32.  Thiel de Bocanegra H, Chang R, Howell M, Darney P. Interpregnancy intervals: 
impact of postpartum contraceptive effectiveness and coverage. Am J Obstet 
Gynecol. 2014;210(4):311.e1-311.e8.  
33.  Ahrens KA, Nelson H, Stidd RL, Moskosky S, Hutcheon JA. Short interpregnancy 
intervals and adverse perinatal outcomes in high‐resource settings: An updated 
systematic review. Paediatr Perinat Epidemiol. 2019 Jan;33(1):O25–47.  
34.  Conde‐Agudelo A, Rosas‐Bermudez A, Castaño F, Norton MH. Effects of Birth 
Spacing on Maternal, Perinatal, Infant, and Child Health: A Systematic Review of 
Causal Mechanisms. Stud Fam Plann. 2012;43(2):93–114.  
35.  Hsieh T-T, Chen S-F, Shau W-Y, Hsieh C-C, Hsu J-J, Hung T-H. The Impact of 
Interpregnancy Interval and Previous Preterm Birth on the Subsequent Risk of 
Preterm Birth. J Soc Gynecol Investig JSGI. 2005 Apr 1;12(3):202–7.  
ICO4MCH LARC INTERVENTION EVALUATION  49 
36.  Shah PS, Balkhair T, Ohlsson A, Beyene J, Scott F, Frick C. Intention to become 
pregnant and low birth weight and preterm birth: a systematic review. Matern Child 
Health J. 2011 Feb;15(2):205–16.  
37.  Shree R, Caughey AB, Chandrasekaran S. Short interpregnancy interval increases 
the risk of preterm premature rupture of membranes and early delivery. J Matern-
Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int 
Soc Perinat Obstet. 2018 Nov;31(22):3014–20.  
38.  Shoupe D. LARC methods: entering a new age of contraception and reproductive 
health. Contracept Reprod Med [Internet]. 2016 Feb 23 [cited 2020 Nov 13];1. 
Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675060/ 
39.  Winner B, Peipert JF, Zhao Q, Buckel C, Madden T, Allsworth JE, et al. 
Effectiveness of Long-Acting Reversible Contraception. N Engl J Med. 
2012;366(21):1998–2007.  
40.  Abajobir AA, Maravilla JC, Alati R, Najman JM. A systematic review and meta-
analysis of the association between unintended pregnancy and perinatal depression. 
J Affect Disord. 2016 Mar 1;192:56–63.  
41.  Cheng D, Schwarz EB, Douglas E, Horon I. Unintended pregnancy and associated 
maternal preconception, prenatal and postpartum behaviors. Contraception. 2009 
Mar 1;79(3):194–8.  
42.  Dibaba Y, Fantahun M, Hindin MJ. The effects of pregnancy intention on the use of 
antenatal care services: systematic review and meta-analysis. Reprod Health. 2013 
Sep 16;10:50.  
43.  Branum AM, Jones J. Trends in long-acting reversible contraception use among 
U.S. women aged 15-44. NCHS Data Brief. 2015 Feb;(188):1–8.  
44.  Finer LB, Jerman J, Kavanaugh ML. Changes in use of long-acting contraceptive 
methods in the United States, 2007–2009. Fertil Steril. 2012 Oct 1;98(4):893–7.  
45.  Kavanaugh ML, Jerman J. Contraceptive method use in the United States: trends 
and characteristics between 2008, 2012 and 2014. Contraception. 2018 
Jan;97(1):14–21.  
46.  Bergin A, Tristan S, Terplan M, Gilliam ML, Whitaker AK. A missed opportunity 
for care: two-visit IUD insertion protocols inhibit placement. Contraception. 2012 
Dec;86(6):694–7.  
47.  Politi MC, Estlund A, Milne A, Buckel CM, Peipert JF, Madden T. Barriers and 
facilitators to implementing a patient-centered model of contraceptive provision in 
community health centers. Contracept Reprod Med [Internet]. 2016 Nov 8 [cited 
2020 Oct 22];1. Available from: 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5693580/ 
ICO4MCH LARC INTERVENTION EVALUATION  50 
48.  Tocce K, Sheeder J, Python J, Teal SB. Long Acting Reversible Contraception in 
Postpartum Adolescents: Early Initiation of Etonogestrel Implant is Superior to 
IUDs in the Outpatient Setting. J Pediatr Adolesc Gynecol. 2012 Feb 1;25(1):59–63.  
49.  Biggs MA, Arons A, Turner R, Brindis CD. Same-day LARC insertion attitudes and 
practices. Contraception. 2013 Nov 1;88(5):629–35.  
50.  Dehlendorf C, Levy K, Ruskin R, Steinauer J. Health care providers’ knowledge 
about contraceptive evidence: a barrier to quality family planning care? 
Contraception. 2010 Apr 1;81(4):292–8.  
51.  Tyler CP, Whiteman MK, Zapata LB, Curtis KM, Hillis SD, Marchbanks PA. 
Health care provider attitudes and practices related to intrauterine devices for 
nulliparous women. Obstet Gynecol. 2012 Apr;119(4):762–71.  
52.  Morgan IA, Tucker C, Urlaub DM, Shuler TO, Cilenti D. Leveraging an Academic-
Practice Partnership to Improve Maternal and Child Health Outcomes in North 
Carolina. N C Med J. 2020 Jan 1;81(1):5–13.  
53.  Gregory E, Martin J, Lee E, Osterman M. Assessing the Quality of Medical and 
Health Data From the 2003 Birth Certificate Revision: Results From New York 
City. Natl Vital Stat Rep. 2019;68(8):1–19.  
54.  Ferré C, Callaghan W, Olson C, Sharma A, Barfield W. Effects of Maternal Age 
and Age-Specific Preterm Birth Rates on Overall Preterm Birth Rates — United 
States, 2007 and 2014. MMWR Morb Mortal Wkly Rep [Internet]. 2016 [cited 2020 
Nov 18];65. Available from: 
http://www.cdc.gov/mmwr/volumes/65/wr/mm6543a1.htm 
55.  Ukah UV, Bayrampour H, Sabr Y, Razaz N, Chan W-S, Lim KI, et al. Association 
between gestational weight gain and severe adverse birth outcomes in Washington 
State, US: A population-based retrospective cohort study, 2004–2013. PLOS Med. 
2019 Dec 30;16(12):e1003009.  
56.  Valero de Bernabé J, Soriano T, Albaladejo R, Juarranz M, Calle ME, Martı́nez D, 
et al. Risk factors for low birth weight: a review. Eur J Obstet Gynecol Reprod Biol. 
2004 Sep 10;116(1):3–15.  
57.  Linden A. Conducting Interrupted Time-series Analysis for Single- and Multiple-
group Comparisons - Ariel Linden, 2015. Stata J [Internet]. 2015 Jun 1 [cited 2020 
Oct 23]; Available from: 
http://journals.sagepub.com/doi/10.1177/1536867X1501500208 
58.  Mascha EJ, Sessler DI. Segmented Regression and Difference-in-Difference 
Methods: Assessing the Impact of Systemic Changes in Health Care. Anesth Analg. 
2019;129(2):618–33.  
ICO4MCH LARC INTERVENTION EVALUATION  51 
59.  Goulding AN, Tucker C, Verbiest S, Bryant K, Stuebe AM. 1087: Differences in 
postpartum receipt of long-acting reversible contraception by sociodemographic 
characteristics. Am J Obstet Gynecol. 2020 Jan 1;222(1):S670–1.  
60.  Kramer RD, Higgins JA, Godecker AL, Ehrenthal DB. Racial and ethnic differences 
in patterns of long-acting reversible contraceptive use in the United States, 2011–
2015. Contraception. 2018 May 1;97(5):399–404.  
61.  Higgins JA, Kramer RD, Ryder KM. Provider Bias in Long-Acting Reversible 
Contraception (LARC) Promotion and Removal: Perceptions of Young Adult 
Women. Am J Public Health. 2016 Sep 15;106(11):1932–7.  
62.  Phelan JC, Link BG. Is Racism a Fundamental Cause of Inequalities in Health? 
Annu Rev Sociol. 2015 Aug 14;41(1):311–30.  
63.  Rutman S, Taualii M, Ned D, Tetrick C. Reproductive Health and Sexual Violence 
Among Urban American Indian and Alaska Native Young Women: Select Findings 
from the National Survey of Family Growth (2002). Matern Child Health J. 2012 












ICO4MCH LARC INTERVENTION EVALUATION  52 
Acknowledgement 
I would like to express my deepest appreciation to the first and second readers of this 
master’s paper, Angela Parcesepe, PhD, and Christine Tucker, PhD. Their meaningful 
feedback and support throughout this process was invaluable. I would also like to thank 
Alison Singer, PhD, who designed and analyzed aim one of this evaluation. The 
statistical interpretations throughout this paper in both aims would not have been possible 
without Alison’s thoughtful guidance and suggestions. Finally, I would like to thank 
Cathy Zimmer, PhD, for devoting weekly meetings to help design and analyze aim two of 
this evaluation. Without the guidance of all women mentioned above, this master’s thesis 












ICO4MCH LARC INTERVENTION EVALUATION  53 
Appendix 
Table 7. Table of Measures 




ICO4MCH funding was determined using 
the county of residence of the mother on 
the child’s birth certificate. 
ICO4MCH funding was 
dichotomized into treatment (1) or 
comparator county (0) of 
residence 
Outcomes 
PTB The preterm birth variable was determined 
using the obstetric estimate of gestation (in 
completed weeks gestation) 
PTB was dichotomized into 
preterm birth (<37 weeks 
completed gestation) (1) or not a 
preterm birth (>37 weeks 
completed gestation) (0) 
LBW The low birth weight outcome was 
determined using the birth weight question 
on the childbirth certificate. 
The continuous birthweight 
variable was dichotomized into: 
1=low birth weight birth (<2500 
grams) 
0=not a low birth weight birth 
(>2500 grams) 
Covariates   
Maternal Age The age of the mother was determined 
using the mother’s year, month, and day of 
birth on the child’s birth certificate. 
Maternal age at the time of birth was 
calculated. 
 
In the analysis, the maternal age variable 
was restricted to women between 10 and 
55 based on advice from NC DPH. 
Maternal age was grouped into the 
following categories: 









The smoking status of the mother was 
determined using the “cigarette smoking 
before and during pregnancy questions” on 
the child’s birth certificate. This variable 
includes the daily averages (# of cigarettes 
or packs smoked) for the 3 months before 
pregnancy and each trimester.  
 
Women with missing smoking data from 
any period were coded as missing. 
Non-smokers (0) were coded as 
women who reported 0 cigarettes 
smoked throughout the 3 months 
before and every trimester during 
pregnancy. Women who reported 
smoking the three months prior to 
pregnancy but not any period 
during pregnancy were coded as 
having stopped smoking prior to 
pregnancy (1). Women who 
smoked pre-pregnancy and 
smoked during the first two 
trimesters but not the third 
trimester were coded as having 
stopped smoking during 
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pregnancy (2). Women were 
coded as having continued 
smoking (3) if they smoked the 
third trimester, even if smoking 
was reduced or smoking was not 
reported in the previous two 
trimesters. 
 
The resulting groups were: 
0=Non-smoker 
1=Stopped before pregnancy 




Maternal education was determined using 
the mother’s education question on the 
child’s birth certificate. 
While the birth certificate includes 
8 categories of education, we 
collapsed these categories into 4: 
1=Less than high school 
2=High School or GED 
3=Some college 




The Medicaid status of the mother was 
determined from the linked Medicaid 
claims data available in the “Babylove” 
dataset. 
Medicaid status was dichotomized 
into enrolled in Medicaid (1) and 
not enrolled in Medicaid (0). 
(Women who had filed a 
Medicaid claim and were 




The maternal race/ethnicity variable was 
determined using the mother’s race 
variable on the child’s birth certificate. A 
non-bridged approach used to further 
categorize variables based on advice from 
NCHS due to concerns with the 
methodology of the bridged race/ethnicity 
categories.  
Maternal Race was grouped into 
the following categories: 
1=Non-Hispanic White 
2=Non-Hispanic Black or African 
American 
3=Non-Hispanic American Indian 
or Alaskan Native 
4= Non-Hispanic Asian or Pacific 
Islander 




The mother’s pre-pregnancy BMI was 
determined using the mother’s reported 
pre-pregnancy weight and the mother’s 
reported height on the child’s birth 
certificate. 
The mother’s BMI was 
categorized into standard BMI 
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Child’s Sex The child’s sex was determined using the 
sex of the child listed on the child’s birth 
certificate. 
Child sex was dichotomized into 
Male (1) and female (2) 
Previous PTB The previous preterm birth variable was 
developed using “risk factors in this 
pregnancy” section on the child’s birth 
certificate. If the question “previous 
preterm birth” was endorsed, a woman was 
coded as having a previous preterm birth 
(1). 
Previous preterm birth was 
dichotomized into No previous 
preterm birth (0) and preterm birth 
(1) 
Parity Parity was determined based on the 
“number of previous live births” question 
on the child’s birth certificate. 
Reported number of previous 
children were categorized into the 
following groups: 
0=Nulliparous 
1=1 prior birth 
2=2-3 prior years 
3=4  prior births 
Pregnancy 
weight gain 
Pre-pregnancy weight gain was developed 
using the mother’s reported weight preg-
pregnancy and at delivery as well as her 
height (to determine BMI). Categories 
were defined as less than adequate, 
adequate, or excessive based on ACOG 
recommendations for pregnancy weight 
gain based on BMI group. 
 
Pre-pregnancy BMI under 18.5: 28–40 
pounds 
Pre-pregnancy BMI 18.5–24.9: 25–35 
pounds 
Pre-pregnancy BMI 25–29.9: 15–25 
pounds 
Pre-pregnancy BMI 30 or more: 11–20  
If a woman fell below the 
recommended pregnancy weight 
gain, she was coded as less than 
adequate weight gain (0). If a 
woman gained over the 
recommended weight, she was 
coded as excessive weight gain 
(2). If a women’s weight gain fell 
within the recommended values, 
she was coded as adequate weight 
gain (1). 
Diabetes The pre-pregnancy or gestational diabetes 
variable was developed using “risk factors 
in this pregnancy” section on the child’s 
birth certificate. The maternal diabetes 
questions separate pre-pregnancy and 
gestational diabetes. For our analysis, 
women were coded as 1 if they 
experienced diabetes either before or 
during pregnancy. 
The diabetes variable was 
dichotomized into no diabetes (0) 
and pre-pregnancy or gestational 
diabetes (1) 
Hypertension The pre-pregnancy or gestational 
hypertension variable was developed using 
“risk factors in this pregnancy” section on 
the child’s birth certificate. The maternal 
The hypertension variable was 
dichotomized into no hypertension 
(0) and pre-pregnancy or 
gestational hypertension (1 
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hypertension questions separate pre-
pregnancy and gestational hypertension. 
For our analysis, a woman was coded as 1 
if they experienced hypertension either 
before or during pregnancy. 
Enrolled in 
WIC 
Whether a mother was enrolled in WIC 
was determined from the child’s birth 
certificate based on the question “Did 
mother get WIC food for herself during 
this pregnancy?” 
0=Not enrolled in WIC, 
1=enrolled in WIC 
Rural-Urban 
Continuum 
The rural-urban variable was defined 
based on the USDA’s UCC 2013 criteria. 
This dataset includes classification for all 
counties in every state. 
 
The mean of all counties in a collaborative 
was used to categorize the county-
aggregate level. 
While this dataset includes 
detailed coding for nine different 
types living areas on the rural-
urban continuum, we collapsed 






RLP or IMR 
Programming 
The indicator variable for additional 
RLP/IMR funding was developed based on 
information shared by the Division of 
Public Health Women’s Health Branch 
using an external dataset that contained 
various funding in North Carolina between 
2016-2018. 
Any county included in this 
analysis (n=69) who received 
either additional funding for 
reproductive life planning or 
infant mortality reduction 
(between 2016-2018) were coded 
as a 1. Counties without these 
programs were coded as 0. 
County 
Aggregate 
The county aggregate adjustment variable 
includes the groups outlined in the 
treatment and control county section. In 
total, there were five treatment groups and 
18 control groups 
A detailed description of county 
aggregates are outlined in the 
“Selection of Treatment and 
Comparator Groups” section 
 
 
 
